11/21
05:31 am
xene
Xenon Pharmaceuticals (NASDAQ:XENE) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
Low
Report
Xenon Pharmaceuticals (NASDAQ:XENE) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
11/18
10:45 am
xene
Rating for XENE
Low
Report
Rating for XENE
11/4
12:09 pm
xene
Xenon Pharmaceuticals (NASDAQ:XENE) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Xenon Pharmaceuticals (NASDAQ:XENE) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
11/4
11:46 am
xene
Rating for XENE
Low
Report
Rating for XENE
11/4
11:46 am
xene
Rating for XENE
Low
Report
Rating for XENE
11/4
11:04 am
xene
Rating for XENE
Low
Report
Rating for XENE
11/4
11:04 am
xene
Rating for XENE
Low
Report
Rating for XENE
11/4
08:09 am
xene
Xenon Pharmaceuticals (NASDAQ:XENE) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $55.00 price target on the stock.
Low
Report
Xenon Pharmaceuticals (NASDAQ:XENE) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $55.00 price target on the stock.
11/4
08:08 am
xene
Xenon Pharmaceuticals (NASDAQ:XENE) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Xenon Pharmaceuticals (NASDAQ:XENE) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
11/4
08:08 am
xene
Xenon Pharmaceuticals (NASDAQ:XENE) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Xenon Pharmaceuticals (NASDAQ:XENE) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
11/4
04:16 am
xene
Rating for XENE
Medium
Report
Rating for XENE
11/4
04:16 am
xene
Rating for XENE
Medium
Report
Rating for XENE
10/8
07:29 am
xene
Xenon Pharmaceuticals (NASDAQ:XENE) was upgraded by analysts at Bloom Burton to a "strong-buy" rating.
Low
Report
Xenon Pharmaceuticals (NASDAQ:XENE) was upgraded by analysts at Bloom Burton to a "strong-buy" rating.
10/7
10:14 am
xene
Xenon Pharmaceuticals (NASDAQ:XENE) had its "outperform" rating reaffirmed by analysts at William Blair.
Low
Report
Xenon Pharmaceuticals (NASDAQ:XENE) had its "outperform" rating reaffirmed by analysts at William Blair.
10/7
10:14 am
xene
Xenon Pharmaceuticals (NASDAQ:XENE) had its "outperform" rating reaffirmed by analysts at William Blair.
Low
Report
Xenon Pharmaceuticals (NASDAQ:XENE) had its "outperform" rating reaffirmed by analysts at William Blair.
10/7
08:07 am
xene
Xenon Pharmaceuticals (NASDAQ:XENE) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $55.00 price target on the stock.
Low
Report
Xenon Pharmaceuticals (NASDAQ:XENE) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $55.00 price target on the stock.
10/7
07:44 am
xene
Rating for XENE
Low
Report
Rating for XENE